Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Debt to Equity (2019 - 2025)

Pulmonx (LUNG) has disclosed Debt to Equity for 7 consecutive years, with $0.62 as the latest value for Q3 2025.

  • Quarterly Debt to Equity rose 56.01% to $0.62 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $0.62 through Sep 2025, up 56.01% year-over-year, with the annual reading at $0.43 for FY2024, 37.64% up from the prior year.
  • Debt to Equity for Q3 2025 was $0.62 at Pulmonx, up from $0.54 in the prior quarter.
  • The five-year high for Debt to Equity was $0.62 in Q3 2025, with the low at $0.0 in Q4 2021.
  • Average Debt to Equity over 5 years is $0.26, with a median of $0.28 recorded in 2023.
  • The sharpest move saw Debt to Equity plummeted 43.98% in 2021, then surged 7950.79% in 2022.
  • Over 5 years, Debt to Equity stood at $0.0 in 2021, then soared by 7950.79% to $0.11 in 2022, then skyrocketed by 179.84% to $0.31 in 2023, then soared by 37.64% to $0.43 in 2024, then skyrocketed by 42.75% to $0.62 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.62, $0.54, and $0.48 for Q3 2025, Q2 2025, and Q1 2025 respectively.